Multiple sclerosis associated with interferon-alpha therapy for chronic myelogenous leukemia
about
Haematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature.Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.Side effects of cytokines approved for therapy.Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping.Fulminant central nervous system demyelination associated with interferon-alpha therapy and hepatitis C virus infection.Concurrent administration of interferon alfa-2b and beta-1a.
P2860
Multiple sclerosis associated with interferon-alpha therapy for chronic myelogenous leukemia
description
im Mai 2002 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 2002
@uk
name
Multiple sclerosis associated ...... r chronic myelogenous leukemia
@en
Multiple sclerosis associated ...... r chronic myelogenous leukemia
@nl
type
label
Multiple sclerosis associated ...... r chronic myelogenous leukemia
@en
Multiple sclerosis associated ...... r chronic myelogenous leukemia
@nl
prefLabel
Multiple sclerosis associated ...... r chronic myelogenous leukemia
@en
Multiple sclerosis associated ...... r chronic myelogenous leukemia
@nl
P2093
P2860
P921
P356
P1476
Multiple sclerosis associated ...... r chronic myelogenous leukemia
@en
P2093
Itaru Kataoka
Katsuji Shinagawa
Mine Harada
Reiko Watanabe
Shinichiro Okamoto
Takehiko Mori
Yoshihiko Shiro
P2860
P304
P356
10.1002/AJH.10090
P50
P577
2002-05-29T00:00:00Z